Atlas Trials

Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment.

Clinical trial NCT04239469 · UNKNOWN

Trial details

NCT number
NCT04239469
Sponsor
Knop Laboratorios
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
FibromyalgiaCannabis
Start date
2020-01-15
Primary completion
2020-06-15
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.